Immunomodulatory Effects

The anti-inflammatory mechanism is about putting out a fire that’s already burning. Immunomodulation is about recalibrating the fire alarm so it stops triggering false alarms in the first place.

This distinction matters for conditions like psoriasis and eczema, where the problem isn’t an infection causing inflammation — it’s the immune system itself malfunctioning. Suppressing inflammation temporarily relieves symptoms. Modulating the immune system’s behaviour addresses the underlying dysfunction.

How it works

Rebalancing, not suppressing. Anti-inflammatory drugs turn down the entire immune response like a volume knob. Immunomodulatory compounds act more like an equaliser — adjusting specific immune channels without silencing the whole system. Humic acids modulate NF-κB signalling, which controls which immune genes get transcribed. Fulvic acids inhibit complement activation — a separate arm of the immune system involved in tissue damage during autoimmune flares.

T-cell effects. In balneotherapy studies, peat treatment courses have been observed to shift T-cell populations and cytokine profiles (Maccarone 2021). In eczema, the immune system is skewed toward Th2 dominance (driving the allergic-type inflammation). In psoriasis, Th17 cells drive the accelerated skin turnover. Evidence suggests peat compounds may help rebalance these skewed responses rather than simply dampening all immune activity.

Hormesis. One intriguing framework for understanding peat’s immunomodulatory effect is hormesis — the idea that low-dose exposure to a mild stressor triggers adaptive protective responses (Galvez 2018). Peat’s complex chemical mixture may act as a mild immune stimulus that strengthens the system’s self-regulation, much as exercise stresses muscles to make them stronger.

Why it matters

Immunomodulation is particularly relevant for:

• Psoriasis — an autoimmune condition where the immune system attacks healthy skin. Modulating the overactive T-cell response addresses the root cause, not just the symptoms (Gams 2020).
• Eczema — where Th2-dominant immune skewing drives allergic inflammation. Rebalancing toward Th1 responses could reduce flare frequency and severity.
• Rosacea — where immune dysregulation drives chronic facial inflammation. Wollina (2009) proposed humic substances for rosacea through two combined routes: UV-B protection (removing a major flare trigger) and α2-adrenergic receptor modulation (potentially reducing flushing). The UV-B protection half of that proposal has since been confirmed directly in vitro — humic acids absorbed UV-B and UV-A radiation and cut UV-induced cell damage by more than 60% (Seel 2012), the same photoprotective effect described elsewhere on this site.

The net effect across conditions is a calming of overactive immune responses without the broad immunosuppression that comes with corticosteroids. This is the distinction that makes peat therapy interesting as a complementary approach — it aims to restore balance rather than impose suppression.

The evidence

The evidence is mostly preclinical — in-vitro studies and animal models showing effects on T-cell activation, macrophage function, and complement pathways. Clinical evidence comes from balneotherapy courses where immune markers were measured before and after treatment. The challenge is that immunomodulatory and anti-inflammatory effects overlap significantly in clinical settings, making it difficult to separate the two. The concept is well-supported by mechanism data but awaits dedicated clinical trials.